Status: current, Defined. Date: 31-Dec 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4495321000168110 | codeine phosphate hemihydrate 30 mg + paracetamol 500 mg tablet, 12 tablets (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4495331000168113 | paracetamol 500 mg + codeine phosphate hemihydrate 30 mg tablet, 12 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| paracetamol 500 mg + codeine phosphate hemihydrate 30 mg tablet, 12 | Is a | paracetamol 500 mg tablet, 12 | true | Inferred relationship | Some | ||
| paracetamol 500 mg + codeine phosphate hemihydrate 30 mg tablet, 12 | has MPUU | paracetamol 500 mg + codeine phosphate hemihydrate 30 mg tablet | true | Inferred relationship | Some | 1621713796 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Codalgin Forte tablet, 12 | Is a | True | paracetamol 500 mg + codeine phosphate hemihydrate 30 mg tablet, 12 | Inferred relationship | Some | |
| Paracetamol/Codeine 500/30 (Apo) tablet, 12 | Is a | True | paracetamol 500 mg + codeine phosphate hemihydrate 30 mg tablet, 12 | Inferred relationship | Some | |
| Neodol Forte 500/30 tablet, 12 | Is a | True | paracetamol 500 mg + codeine phosphate hemihydrate 30 mg tablet, 12 | Inferred relationship | Some | |
| Paramax Forte 500/30 tablet, 12 | Is a | True | paracetamol 500 mg + codeine phosphate hemihydrate 30 mg tablet, 12 | Inferred relationship | Some | |
| Paracetamol Codeine 500/30 (GPPL) tablet, 12 | Is a | True | paracetamol 500 mg + codeine phosphate hemihydrate 30 mg tablet, 12 | Inferred relationship | Some | |
| Coparadeine Forte 500/30 tablet, 12 | Is a | True | paracetamol 500 mg + codeine phosphate hemihydrate 30 mg tablet, 12 | Inferred relationship | Some |
Reference Sets
Tasmania reportable Schedule 4 medications reference set
Victoria reportable Schedule 4 medications reference set
South Australia reportable Schedule 4 medications reference set
Queensland Health QScript Schedule 4 monitored medicines reference set
New South Wales Reportable Schedule 4 medications reference set
Northern Territory Reportable Schedule 4 medications reference set
ACT Reportable Schedule 4 medications reference set
Western Australia Health Schedule 4 restricted medicines for public hospitals reference set
Medicinal product pack reference set
FHIR